ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer

Guillaume Passot^{1

2}, Jean-Nicolas Vauthey¹, Yun Shin Chun³

Affiliations

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Surgical Oncology, Hospices Civils de Lyon, CH Lyon Sud, EMR 37-38 University Lyon 1, Lyon, France.
³ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. yschun@mdanderson.org.

Comment

Guillaume Passot et al. Ann Surg Oncol. 2018 Dec.

. 2018 Dec;25(Suppl 3):850-851.

doi: 10.1245/s10434-018-7020-6. Epub 2018 Nov 12.

Guillaume Passot^{1

2}, Jean-Nicolas Vauthey¹, Yun Shin Chun³

¹ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Surgical Oncology, Hospices Civils de Lyon, CH Lyon Sud, EMR 37-38 University Lyon 1, Lyon, France.
³ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. yschun@mdanderson.org.

No abstract available

Comment on

Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
Passot G, Kim BJ, Glehen O, Mehran RJ, Kopetz SE, Goere D, Overman MJ, Pocard M, Marchal F, Conrad C, Aloia TA, Vauthey JN, Chun YS; BIG-RENAPE Working Group. Passot G, et al. Ann Surg Oncol. 2018 Jan;25(1):179-187. doi: 10.1245/s10434-017-6141-7. Epub 2017 Oct 25. Ann Surg Oncol. 2018. PMID: 29071660